Effects of synthetic oral oestrogens in normal men and patients with prostatic carcinoma: lack of gonadotrophin suppression by chlorotrianisene.
D000284:Administration, Oral; D000328:Adult; D000818:Animals; D002369:Castration; D002741:Chlorotrianisene / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood*; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy*; D013739:Testosterone / Q000097:blood
D013739:Testosterone; D002741:Chlorotrianisene; D004054:Diethylstilbestrol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone